UK company record
Isomorphic Labs
AI drug discovery / computational biology; AI drug discovery / foundation models
CandidateCore UK
Snapshot
- UK location
- London · London
- Sector
- AI / ML / data
- Latest recorded round
- Series B
- Latest recorded amount
- $600M initial close; reported extended to ~$2.1B with new investors
- Date
- 2026-05-01
Legal-identity layer
Candidate identity.
- Selected legal name
- ISOMORPHIC LABS LIMITED
- Company number
- 13223825
- Companies House status
- active
- Incorporated
- 2021-02-24
Investors
- AlphabetParticipant
- CapitalGParticipant
- GVParticipant
- MGXParticipant
- TemasekParticipant
- Thrive CapitalLead
- UK Sovereign AI FundParticipant
Current directors and active controllers
- ABOGADO NOMINEES LIMITEDCurrent director
- Alphabet Inc.Active controller
- BOHAN, Valentine AnthonyCurrent director
- YI, Kenneth HoheeCurrent director
Funding rows
- Series B$2.1B · 2026-05-12
Sources
- https://www.isomorphiclabs.com/articles/isomorphic-labs-announces-600m-external-investment-round
- https://techcrunch.com/2025/03/31/alphabets-ai-drug-discovery-platform-isomorphic-labs-raises-600m-from-thrive/
- https://www.fiercebiotech.com/biotech/alphabets-ai-biotech-isomorphic-labs-bags-21b-series-b-fuel-next-gen-drug-design-model
- https://techcrunch.com/2025/03/31/alphabets-ai-drug-discovery-platform-isomorphic-labs-raises-600m-from-thrive/
- https://www.fiercebiotech.com/biotech/alphabets-ai-biotech-isomorphic-labs-bags-21b-series-b-fuel-next-gen-drug-design-model
- https://www.isomorphiclabs.com/articles/isomorphic-labs-announces-series-b-investment-round